Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


8 Am J Med
1 Antiviral Res
1 Cell
2 Epidemiol Infect
2 Eur J Epidemiol
4 J Exp Med
2 J Gen Virol
1 J Immunol
3 J Virol
5 J Virol Methods
6 Lancet
8 MMWR Morb Mortal Wkly Rep
10 N Engl J Med
2 Pediatrics
35 PLoS One
5 Proc Natl Acad Sci U S A
8 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Med

    The Reply.
    Am J Med. 2021;134:e298.

  2. SOKOLSKI M, Gajewski P, Zymlinski R, Biegus J, et al
    Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across Europe.
    Am J Med. 2021;134:482-489.
    PubMed         Abstract available

  3. MAHAJAN S, Srinivasan R, Redlich CA, Huston SK, et al
    Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study.
    Am J Med. 2021;134:526-534.
    PubMed         Abstract available

  4. SIDDIQI HK, Weber B, Zhou G, Regan J, et al
    Increased Prevalence of Myocardial Injury in Patients with SARS-CoV-2 Viremia.
    Am J Med. 2021;134:542-546.
    PubMed         Abstract available

  5. ALPERT JS, Boylston AW
    A Call to Arms: The War of the COVID.
    Am J Med. 2021;134:413-414.

  6. HORWITZ R, Maizes V
    Integrative Medicine and the Long Hauler Syndrome-We Meet Again.
    Am J Med. 2021;134:418-419.

  7. BRIGHAM E, O'Toole J, Kim SY, Friedman M, et al
    The Johns Hopkins Post-Acute COVID-19 Team (PACT): A Multidisciplinary, Collaborative, Ambulatory Framework Supporting COVID-19 Survivors.
    Am J Med. 2021;134:462-467.

    The Brazilian Scientific Denialism Through The American Journal of Medicine.
    Am J Med. 2021;134:415-416.

    Antiviral Res

  9. SVYATCHENKO SV, Goncharova NI, Marchenko VY, Kolosova NP, et al
    An influenza A(H5N8) virus isolated during an outbreak at a poultry farm in Russia in 2017 has an N294S substitution in the neuraminidase and shows reduced susceptibility to oseltamivir.
    Antiviral Res. 2021 Apr 29:105079. doi: 10.1016/j.antiviral.2021.105079.
    PubMed         Abstract available


  10. JAVID B, Bassler D, Bryant MB, Cevik M, et al
    Should masks be worn outdoors?
    BMJ. 2021;373:n1036.

  11. BARTOSZKO JJ, Siemieniuk RAC, Kum E, Qasim A, et al
    Prophylaxis against covid-19: living systematic review and network meta-analysis.
    BMJ. 2021;373:n949.
    PubMed         Abstract available

  12. ESSEX R, Talagala I, Dada O, Rao M, et al
    Clinical Excellence Awards-time for a fairer NHS rewards scheme.
    BMJ. 2021;373:n876.


  13. LEBLANC EV, Colpitts CC
    SARS-CoV-2 RNA: Exclusive friends and common foes.
    Cell. 2021;184:2276-2278.
    PubMed         Abstract available

    Epidemiol Infect

  14. BAGGIO JAO, Machado MF, Carmo RFD, Armstrong ADC, et al
    COVID-19 in Brazil: spatial risk, social vulnerability, human development, clinical manifestations and predictors of mortality - a retrospective study with data from 59 695 individuals.
    Epidemiol Infect. 2021;149:e100.
    PubMed         Abstract available

  15. DRESSLER A, Finci I, Wagner-Wiening C, Eichner M, et al
    Epidemiological analysis of 3,219 COVID-19 outbreaks in the state of Baden-Wuerttemberg, Germany.
    Epidemiol Infect. 2021;149:e101.
    PubMed         Abstract available

    Eur J Epidemiol

  16. BUSHMAN M, Worby C, Chang HH, Kraemer MUG, et al
    Transmission of SARS-CoV-2 before and after symptom onset: impact of nonpharmaceutical interventions in China.
    Eur J Epidemiol. 2021;36:429-439.
    PubMed         Abstract available

  17. DE SOUZA FSH, Hojo-Souza NS, da Silva CM, Guidoni DL, et al
    Second wave of COVID-19 in Brazil: younger at higher risk.
    Eur J Epidemiol. 2021;36:441-443.

    J Exp Med

  18. SOLFOROSI L, Kuipers H, Jongeneelen M, Rosendahl Huber SK, et al
    Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.
    J Exp Med. 2021;218.
    PubMed         Abstract available

  19. SANCHO-SHIMIZU V, Brodin P, Cobat A, Biggs CM, et al
    SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
    J Exp Med. 2021;218.
    PubMed         Abstract available

  20. BAUM A, Kyratsous CA
    SARS-CoV-2 spike therapeutic antibodies in the age of variants.
    J Exp Med. 2021;218.
    PubMed         Abstract available

  21. KEDL RM
    Down but far from out: The durability of SARS-CoV-2 immunity after asymptomatic infection.
    J Exp Med. 2021;218.
    PubMed         Abstract available

    J Gen Virol

  22. DAVIES K, Buczkowski H, Welch SR, Green N, et al
    Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes.
    J Gen Virol. 2021;102.
    PubMed         Abstract available

  23. DISSANAYAKE TK, Yan B, Ng AC, Zhao H, et al
    Differential role of sphingomyelin in influenza virus, rhinovirus and SARS-CoV-2 infection of Calu-3 cells.
    J Gen Virol. 2021;102.
    PubMed         Abstract available

    J Immunol

  24. YAN Q, Li P, Ye X, Huang X, et al
    Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients.
    J Immunol. 2021;206:2146-2159.
    PubMed         Abstract available

    J Virol

  25. LEE W, Kingstad-Bakke B, Kedl RM, Kawaoka Y, et al
    CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
    J Virol. 2021 May 5. pii: JVI.00530-21. doi: 10.1128/JVI.00530.
    PubMed         Abstract available

  26. HORMAN WSJ, Kedzierska K, Rootes CL, Bean AGD, et al
    Upregulated expression of ferret Interferon-Inducible Transmembrane genes by IFN-alpha and influenza virus infection.
    J Virol. 2021 May 5. pii: JVI.00111-21. doi: 10.1128/JVI.00111.
    PubMed         Abstract available

  27. BINJAWADAGI B, Ma Y, Binjawadagi R, Brakel K, et al
    Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats.
    J Virol. 2021;95.
    PubMed         Abstract available

    J Virol Methods

  28. TELWATTE S, Kumar N, Vallejo-Gracia A, Kumar GR, et al
    Novel RT-ddPCR assays for simultaneous quantification of multiple noncoding and coding regions of SARS-CoV-2 RNA.
    J Virol Methods. 2021;292:114115.
    PubMed         Abstract available

  29. PARAI D, Dash GC, Choudhary HR, Peter A, et al
    Diagnostic accuracy comparison of three fully automated chemiluminescent immunoassay platforms for the detection of SARS-CoV-2 antibodies.
    J Virol Methods. 2021;292:114121.
    PubMed         Abstract available

  30. MULLER K, Girl P, von Buttlar H, Dobler G, et al
    Comparison of two commercial surrogate ELISAs to detect a neutralising antibody response to SARS-CoV-2.
    J Virol Methods. 2021;292:114122.
    PubMed         Abstract available

  31. SOLEIMANI R, Khourssaji M, Aupaix A, Rodriguez-Villalobos H, et al
    Usefulness of a multiplex immunodot in case of discordant results between automated COVID-19 serological assays.
    J Virol Methods. 2021;292:114129.
    PubMed         Abstract available

  32. LIANG Y, Yan H, Huang L, Zhao J, et al
    A luciferase immunosorbent assay for quantitative detection of IgG antibodies against SARS-CoV-2 nucleoprotein.
    J Virol Methods. 2021;292:114141.
    PubMed         Abstract available


  33. BROOKS JT, Butler JC, Redfield RR
    Universal Masking to Prevent SARS-CoV-2 Transmission-The Time Is Now.
    JAMA. 2020 Jul 14. pii: 2768532. doi: 10.1001/jama.2020.13107.

  34. HALEY DF, Saitz R
    The Opioid Epidemic During the COVID-19 Pandemic.
    JAMA. 2020 Sep 18. pii: 2770985. doi: 10.1001/jama.2020.18543.

  35. NELSON EJ, McKune SL, Ryan KA, Lednicky JA, et al
    SARS-CoV-2 Positivity on or After 9 Days Among Quarantined Student Contacts of Confirmed Cases.
    JAMA. 2021 Feb 19. pii: 2776857. doi: 10.1001/jama.2021.2392.

  36. GHARPURE R, Patel A, Link-Gelles R
    First-Dose COVID-19 Vaccination Coverage Among Skilled Nursing Facility Residents and Staff.
    JAMA. 2021 Feb 24. pii: 2777023. doi: 10.1001/jama.2021.2352.

  37. LIVINGSTON EH, Malani PN, Creech CB
    The Johnson & Johnson Vaccine for COVID-19.
    JAMA. 2021 Mar 1. pii: 2777172. doi: 10.1001/jama.2021.2927.

  38. BLUMENTHAL KG, Robinson LB, Camargo CA Jr, Shenoy ES, et al
    Acute Allergic Reactions to mRNA COVID-19 Vaccines.
    JAMA. 2021 Mar 8. pii: 2777417. doi: 10.1001/jama.2021.3976.

  39. CHRISTIE A, Mbaeyi SA, Walensky RP
    CDC Interim Recommendations for Fully Vaccinated People: An Important First Step.
    JAMA. 2021 Mar 10. pii: 2777536. doi: 10.1001/jama.2021.4367.

  40. STEPHENSON KE, Le Gars M, Sadoff J, de Groot AM, et al
    Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.
    JAMA. 2021 Mar 11. pii: 2777598. doi: 10.1001/jama.2021.3645.
    PubMed         Abstract available

  41. MORIN L, Savale L, Pham T, Colle R, et al
    Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19.
    JAMA. 2021 Mar 17. pii: 2777787. doi: 10.1001/jama.2021.3331.
    PubMed         Abstract available

  42. SADEGHIPOUR P, Talasaz AH, Rashidi F, Sharif-Kashani B, et al
    Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Cl
    JAMA. 2021 Mar 18. pii: 2777829. doi: 10.1001/jama.2021.4152.
    PubMed         Abstract available

  43. GILL PJ, Mahant S, Hall M, Berry JG, et al
    Reasons for Admissions to US Children's Hospitals During the COVID-19 Pandemic.
    JAMA. 2021;325:1676-1679.


  44. MFINANGA SG, Mnyambwa NP, Minja DT, Ntinginya NE, et al
    Tanzania's position on the COVID-19 pandemic.
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00678.

  45. KADIWAR S, Smith JJ, Ledot S, Johnson M, et al
    Were pregnant women more affected by COVID-19 in the second wave of the pandemic?
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00716.

  46. STOEKLE HC, Ivasilevitch A, Herve C
    COVID-19: time for ethical reflection?
    Lancet. 2021 Apr 16. pii: S0140-6736(21)00795.

  47. CLAESON M, Hanson S
    The Swedish COVID-19 strategy revisited.
    Lancet. 2021 Apr 19. pii: S0140-6736(21)00885.

  48. DEAN N
    Hospital admissions due to COVID-19 in Scotland after one dose of vaccine.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00765.

  49. GUPTA S, Leaf DE
    Tocilizumab in COVID-19: some clarity amid controversy.
    Lancet. 2021;397:1599-1601.

    MMWR Morb Mortal Wkly Rep

  50. MILLER JS, Holshue M, Dostal TKH, Newman LP, et al
    COVID-19 Outbreak Among Farmworkers - Okanogan County, Washington, May-August 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:617-621.
    PubMed         Abstract available

  51. CAVANAUGH AM, Fortier S, Lewis P, Arora V, et al
    COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program - Kentucky, March 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:639-643.
    PubMed         Abstract available

  52. TERAN RA, Walblay KA, Shane EL, Xydis S, et al
    Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members - Chicago, Illinois, December 2020-March 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:632-638.
    PubMed         Abstract available

  53. MACNEIL JR, Su JR, Broder KR, Guh AY, et al
    Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:651-656.
    PubMed         Abstract available

  54. FEDER KA, Pearlowitz M, Goode A, Duwell M, et al
    Linked Clusters of SARS-CoV-2 Variant B.1.351 - Maryland, January-February 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:627-631.
    PubMed         Abstract available

  55. HERNANDEZ-ROMIEU AC, Leung S, Mbanya A, Jackson BR, et al
    Health Care Utilization and Clinical Characteristics of Nonhospitalized Adults in an Integrated Health Care System 28-180 Days After COVID-19 Diagnosis - Georgia, May 2020-March 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:644-650.
    PubMed         Abstract available

  56. PORTER KA, Ramaswamy M, Koloski T, Castrodale L, et al
    COVID-19 Among Workers in the Seafood Processing Industry: Implications for Prevention Measures - Alaska, March-October 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:622-626.
    PubMed         Abstract available

  57. TENFORDE MW, Olson SM, Self WH, Talbot HK, et al
    Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged >/=65 Years - United States, January-March 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:674-679.
    PubMed         Abstract available

    N Engl J Med

    Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden.
    N Engl J Med. 2021 Mar 1. pii: 10.1056/NEJMc2101280.

  59. BESANCON L, Steadson D, Flahault A
    Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden.
    N Engl J Med. 2021 Mar 1. pii: 10.1056/NEJMc2101280.

    Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden. Reply.
    N Engl J Med. 2021 Mar 1. pii: 10.1056/NEJMc2101280.

  61. KRAMER DB, Opel DJ, Parasidis E, Mello MM, et al
    Choices in a Crisis - Individual Preferences among SARS-CoV-2 Vaccines.
    N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2102146.

  62. BARSKY BA, Reinhart E, Farmer P, Keshavjee S, et al
    Vaccination plus Decarceration - Stopping Covid-19 in Jails and Prisons.
    N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2100609.

  63. KRUTIKOV M, Hayward A, Shallcross L
    Spread of a Variant SARS-CoV-2 in Long-Term Care Facilities in England.
    N Engl J Med. 2021 Mar 16. doi: 10.1056/NEJMc2035906.

  64. KADAKIA KT, Beckman AL, Ross JS, Krumholz HM, et al
    Leveraging Open Science to Accelerate Research.
    N Engl J Med. 2021;384:e61.

  65. ROMANO CM, Felix AC, Pannuti CS
    Viable SARS-CoV-2 Shedding.
    N Engl J Med. 2021;384.

  66. KIM MC, Park MS, Chung JW
    Viable SARS-CoV-2 Shedding. Reply.
    N Engl J Med. 2021;384.

  67. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Advice for Clinicians on Covid-19 Vaccines and Social Restrictions.
    N Engl J Med. 2021;384:e77.


  68. HE Y, Vinci RJ
    Uncertainty in the COVID-19 Pandemic and the Art of Medicine.
    Pediatrics. 2021;147.

  69. FOUDA GGA, Kwiek JJ, Yotebieng M
    Safety of Breastfeeding by Mothers With COVID-19: New Evidence From Israel.
    Pediatrics. 2021;147.

    PLoS One

  70. PASQUALOTTO AC, Pereira PC, Lana DFD, Schwarzbold AV, et al
    COVID-19 seroprevalence in military police force, Southern Brazil.
    PLoS One. 2021;16:e0249672.
    PubMed         Abstract available

  71. TSOUNGUI OBAMA HCJ, Adil Mahmoud Yousif N, Alawam Nemer L, Ngougoue Ngougoue PM, et al
    Preventing COVID-19 spread in closed facilities by regular testing of employees-An efficient intervention in long-term care facilities and prisons?
    PLoS One. 2021;16:e0249588.
    PubMed         Abstract available

  72. CHOI R, Zhou M, Shek R, Wilson JW, et al
    High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity.
    PLoS One. 2021;16:e0250019.
    PubMed         Abstract available

  73. SHIFERAW KB, Mengiste SA, Gullslett MK, Zeleke AA, et al
    Healthcare providers' acceptance of telemedicine and preference of modalities during COVID-19 pandemics in a low-resource setting: An extended UTAUT model.
    PLoS One. 2021;16:e0250220.
    PubMed         Abstract available

  74. BAGGIO S, Spechbach H, Vernaz N, Guessous I, et al
    SARS-CoV-2 testing strategy: A comparison of restricted and extended strategies in a Swiss outpatient cohort from the community and hospital employees.
    PLoS One. 2021;16:e0250021.
    PubMed         Abstract available

  75. BALL L, Alberti S, Belfortini C, Almondo C, et al
    Effects of distancing and pattern of breathing on the filtering capability of commercial and custom-made facial masks: An in-vitro study.
    PLoS One. 2021;16:e0250432.
    PubMed         Abstract available

  76. TOLU LB, Ezeh A, Feyissa GT
    Vertical transmission of Severe Acute Respiratory Syndrome Coronavirus 2: A scoping review.
    PLoS One. 2021;16:e0250196.
    PubMed         Abstract available

  77. JABER RM, Mafrachi B, Al-Ani A, Shkara M, et al
    Awareness and perception of COVID-19 among the general population: A Middle Eastern survey.
    PLoS One. 2021;16:e0250461.
    PubMed         Abstract available

  78. CAMPEDELLI GM, D'Orsogna MR
    Temporal clustering of disorder events during the COVID-19 pandemic.
    PLoS One. 2021;16:e0250433.
    PubMed         Abstract available

  79. CARDONA-PEREZ JA, Villegas-Mota I, Helguera-Repetto AC, Acevedo-Gallegos S, et al
    Prevalence, clinical features, and outcomes of SARS-CoV-2 infection in pregnant women with or without mild/moderate symptoms: Results from universal screening in a tertiary care center in Mexico City, Mexico.
    PLoS One. 2021;16:e0249584.
    PubMed         Abstract available

  80. ADIL MAHMOUD YOUSIF N, Tsoungui Obama HCJ, Ngucho Mbeutchou YJ, Kwamou Ngaha SF, et al
    The impact of COVID-19 vaccination campaigns accounting for antibody-dependent enhancement.
    PLoS One. 2021;16:e0245417.
    PubMed         Abstract available

  81. PADGETT LR, Kennington LA, Ahls CL, Samarasinghe DK, et al
    Polyester nasal swabs collected in a dry tube are a robust and inexpensive, minimal self-collection kit for SARS-CoV-2 testing.
    PLoS One. 2021;16:e0245423.
    PubMed         Abstract available

  82. FASSY J, Lacoux C, Leroy S, Noussair L, et al
    Versatile and flexible microfluidic qPCR test for high-throughput SARS-CoV-2 and cellular response detection in nasopharyngeal swab samples.
    PLoS One. 2021;16:e0243333.
    PubMed         Abstract available

  83. LOHINIVA AL, Dub T, Hagberg L, Nohynek H, et al
    Learning about COVID-19-related stigma, quarantine and isolation experiences in Finland.
    PLoS One. 2021;16:e0247962.
    PubMed         Abstract available

  84. WAN KS, Tok PSK, Yoga Ratnam KK, Aziz N, et al
    Implementation of a COVID-19 surveillance programme for healthcare workers in a teaching hospital in an upper-middle-income country.
    PLoS One. 2021;16:e0249394.
    PubMed         Abstract available

  85. RAVINDRA VM, Grandhi R, Delic A, Hohmann S, et al
    Impact of COVID-19 on the hospitalization, treatment, and outcomes of intracerebral and subarachnoid hemorrhage in the United States.
    PLoS One. 2021;16:e0248728.
    PubMed         Abstract available

  86. EASTMAN B, Meaney C, Przedborski M, Kohandel M, et al
    Modeling the impact of public response on the COVID-19 pandemic in Ontario.
    PLoS One. 2021;16:e0249456.
    PubMed         Abstract available

  87. FISCHER CB, Adrien N, Silguero JJ, Hopper JJ, et al
    Mask adherence and rate of COVID-19 across the United States.
    PLoS One. 2021;16:e0249891.
    PubMed         Abstract available

    Impact of the COVID-19 pandemic on the social and educational aspects of Saudi university students' lives.
    PLoS One. 2021;16:e0250026.
    PubMed         Abstract available

  89. ESSLER JL, Kane SA, Nolan P, Akaho EH, et al
    Discrimination of SARS-CoV-2 infected patient samples by detection dogs: A proof of concept study.
    PLoS One. 2021;16:e0250158.
    PubMed         Abstract available

  90. ZHAO H, Merchant NN, McNulty A, Radcliff TA, et al
    COVID-19: Short term prediction model using daily incidence data.
    PLoS One. 2021;16:e0250110.
    PubMed         Abstract available

  91. BRONDANI M, Almeida F, Cua D, Maragha T, et al
    Uncertainties around COVID-19 from the perspectives of oral health care workers during the first wave of SARS-CoV-2 infections in British Columbia, Canada.
    PLoS One. 2021;16:e0249186.
    PubMed         Abstract available

  92. KHAN MS, Dogra R, Miriyala LKV, Salman FNU, et al
    Clinical characteristics and outcomes of patients with Corona Virus Disease 2019 (COVID-19) at Mercy Health Hospitals, Toledo, Ohio.
    PLoS One. 2021;16:e0250400.
    PubMed         Abstract available

  93. WULKOW H, Conrad TOF, Djurdjevac Conrad N, Muller SA, et al
    Prediction of Covid-19 spreading and optimal coordination of counter-measures: From microscopic to macroscopic models to Pareto fronts.
    PLoS One. 2021;16:e0249676.
    PubMed         Abstract available

  94. GRUNDMANN F, Epstude K, Scheibe S
    Face masks reduce emotion-recognition accuracy and perceived closeness.
    PLoS One. 2021;16:e0249792.
    PubMed         Abstract available

  95. VERSCHUUR J, Koks EE, Hall JW
    Global economic impacts of COVID-19 lockdown measures stand out in high-frequency shipping data.
    PLoS One. 2021;16:e0248818.
    PubMed         Abstract available

  96. ABEDIN M, Islam MA, Rahman FN, Reza HM, et al
    Willingness to vaccinate against COVID-19 among Bangladeshi adults: Understanding the strategies to optimize vaccination coverage.
    PLoS One. 2021;16:e0250495.
    PubMed         Abstract available

  97. SMIT AN, Juda M, Livingstone A, U SR, et al
    Impact of COVID-19 social-distancing on sleep timing and duration during a university semester.
    PLoS One. 2021;16:e0250793.
    PubMed         Abstract available

  98. AL-RAHIMI JS, Nass NM, Hassoubah SA, Wazqar DY, et al
    Levels and predictors of fear and health anxiety during the current outbreak of COVID-19 in immunocompromised and chronic disease patients in Saudi Arabia: A cross-sectional correlational study.
    PLoS One. 2021;16:e0250554.
    PubMed         Abstract available

  99. COSTANTINO G, Solbiati M, Elli S, Paganuzzi M, et al
    Utility of hospitalization for elderly individuals affected by COVID-19.
    PLoS One. 2021;16:e0250730.
    PubMed         Abstract available

  100. TSUBOI N, Sasaki T, Kashihara N, Yokoo T, et al
    Proteinuria changes in kidney disease patients with clinical remission during the COVID-19 pandemic.
    PLoS One. 2021;16:e0250581.
    PubMed         Abstract available

  101. EL-ELIMAT T, AbuAlSamen MM, Almomani BA, Al-Sawalha NA, et al
    Acceptance and attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan.
    PLoS One. 2021;16:e0250555.
    PubMed         Abstract available

  102. WU D, Mac Aonghusa P, O'Shea DF
    Correlation of national and healthcare workers COVID-19 infection data; implications for large-scale viral testing programs.
    PLoS One. 2021;16:e0250699.
    PubMed         Abstract available

  103. CHOI I, Kim JH, Kim N, Choi E, et al
    How COVID-19 affected mental well-being: An 11- week trajectories of daily well-being of Koreans amidst COVID-19 by age, gender and region.
    PLoS One. 2021;16:e0250252.
    PubMed         Abstract available

  104. DERINGTON CG, Cohen JB, Mohanty AF, Greene TH, et al
    Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans.
    PLoS One. 2021;16:e0248080.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  105. MORSELLI GYSI D, do Valle I, Zitnik M, Ameli A, et al
    Network medicine framework for identifying drug-repurposing opportunities for COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  106. NI X, Ouyang W, Jeong H, Kim JT, et al
    Automated, multiparametric monitoring of respiratory biomarkers and vital signs in clinical and home settings for COVID-19 patients.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  107. PYMM P, Adair A, Chan LJ, Cooney JP, et al
    Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  108. DONG C, Wang Y, Gonzalez GX, Ma Y, et al
    Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  109. STAMBAUGH A, Parks JW, Stott MA, Meena GG, et al
    Optofluidic multiplex detection of single SARS-CoV-2 and influenza A antigens using a novel bright fluorescent probe assay.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


  110. PU J, Yu Q, Yin Z, Zhang Y, et al
    The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial.
    Vaccine. 2021 Apr 9. pii: S0264-410X(21)00431.
    PubMed         Abstract available

  111. DANIELS V, Saxena K, Roberts C, Kothari S, et al
    Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis.
    Vaccine. 2021 Apr 6. pii: S0264-410X(21)00428.
    PubMed         Abstract available

  112. GRAMACHO WG, Turgeon M
    When politics collides with public health: COVID-19 vaccine country of origin and vaccination acceptance in Brazil.
    Vaccine. 2021 Apr 6. pii: S0264-410X(21)00396.
    PubMed         Abstract available

  113. KINI A, Morgan R, Kuo H, Shea P, et al
    Differences and disparities in seasonal influenza vaccine, acceptance, adverse reactions, and coverage by age, sex, gender, and race.
    Vaccine. 2021 Apr 28. pii: S0264-410X(21)00448.
    PubMed         Abstract available

  114. HATZIANTONIOU S, Maltezou HC, Tsakris A, Poland GA, et al
    Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study.
    Vaccine. 2021 Apr 6. pii: S0264-410X(21)00377.

  115. SALMON DA, Dudley MZ, Brewer J, Kan L, et al
    COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization.
    Vaccine. 2021 Mar 24. pii: S0264-410X(21)00315.
    PubMed         Abstract available

  116. CHU L, McPhee R, Huang W, Bennett H, et al
    A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine.
    Vaccine. 2021 Feb 9. pii: S0264-410X(21)00153.
    PubMed         Abstract available

  117. BLACK SB, Law B, Chen RT, Dekker CL, et al
    The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety.
    Vaccine. 2021 Mar 6. pii: S0264-410X(21)00284.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.